The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. AnaptysBio Inc shares valued at $64,268 were sold by Faga Daniel on Mar 25 ’24. At $21.42 per share, Faga Daniel sold 3,000 shares. The insider’s holdings dropped to 749,087 shares worth approximately $19.49 million following the completion of this transaction.
Also, Faga Daniel sold 145,940 shares, netting a total of over 3,325,185 in proceeds. Following the sale of shares at $22.78 each, the insider now holds 752,087 shares.
Before that, LOUMEAU ERIC J had sold 5,000 shares from its account. In a trade valued at $125,000, the CHIEF LEGAL OFFICER traded AnaptysBio Inc shares for $25.00 each. Upon closing the transaction, the insider’s holdings decreased to 5,000 shares, worth approximately $84304.8.
As published in their initiating research note from Leerink Partners on April 16, 2024, AnaptysBio Inc [ANAB] has been an Outperform and the price target has been revised to $47. Analysts at Wells Fargo started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid April. As of March 12, 2024, Wedbush has increased its “Neutral” rating to a “an Outperform” for ANAB. Earlier on February 26, 2024, BTIG Research initiated its rating. Their recommendation was “a Buy” for ANAB stock.
Analyzing ANAB Stock Performance
During the last five days, there has been a surge of approximately 35.03%. Over the course of the year, AnaptysBio Inc shares have jumped approximately 21.48%. Shares of the company reached a 52-week high of $27.50 on 02/26/24 and a 52-week low of $18.49 on 04/25/24. A 50-day SMA is recorded $22.95, while a 200-day SMA reached $20.14. Nevertheless, trading volume fell to 0.79 million shares from 1.1 million shares the previous day.
Support And Resistance Levels for AnaptysBio Inc (ANAB)
According to the 24-hour chart, there is a support level at 24.82, which, if violated, would cause prices to drop to 23.61. In the upper region, resistance lies at 26.79. The next price resistance is at 27.55. RSI (Relative Strength Index) is 66.66 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.73, which suggests the price will increase in the coming days. Percent R is at 4.20%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
